Biotech joins EuropaBio: effective, bio-based alternatives to conventional chemical-synthetic production processes
Brussels, 29 June 2021 – EuropaBio is pleased to announce that EV Biotech has joined as an associate member.
Founded in 2018 as a biotechnology start-up creating microbial production platforms for high-value chemicals and proteins, EV Biotech looks to revolutionise microbial strain engineering using computational modelling and microorganisms. Offering a synergistic combination of in-silico modelling and precision strain engineering, EV Biotech aims to facilitate the industrial transition towards sustainable chemical manufacturing.
EuropaBio Director-General Dr. Claire Skentelbery commented “We are glad to have another start-up on board. Together, we will strive to push forward policy enabling a better regulatory environment for biotechnology within Europe, as well as to shape priorities for SMEs and promote our innovative platform to drive the Green Deal revolution”.
EV Biotech CEO Linda Dijkshoorn added “By joining EuropaBio, we aim to facilitate the discussion of green chemical production and promote innovative solutions for sustainable biotechnology. As a start-up focused on sustainable chemical compound development, we aim to demonstrate the industrial opportunities available utilising green chemistry to facilitate this change”.